Literature DB >> 29017389

The Canadian laboratory initiative on pediatric reference intervals: A CALIPER white paper.

Khosrow Adeli1,2, Victoria Higgins1,2, Karin Trajcevski1, Nicole White-Al Habeeb2.   

Abstract

Laboratory investigations provide physicians with objective data to aid in disease diagnosis, clinical decision making, and patient follow up. Clinical interpretation of laboratory test results relies heavily on the availability of appropriate population-based reference intervals (i.e. normative values) or decision limits developed through clinical outcome studies. Although reference intervals are fundamental to accurate laboratory test interpretation, and thus critically important to healthcare, the need for sound evidence-based reference intervals has been largely overlooked, particularly in the pediatric population. In the field of pediatric laboratory medicine, accurate age- and sex-specific reference intervals established using samples from healthy children and adolescents have not been readily available, forcing many clinical laboratories to report adult reference intervals with pediatric test results. When pediatric reference intervals are available, they have often been established with a small sample size, inpatient or outpatient samples, outdated methodologies, and/or inappropriate statistical procedures. To address these unacceptable limitations, several national and global initiatives have begun to close the critical evidence gaps in pediatric reference intervals. Notably, the Canadian Laboratory Initiative on Pediatric Reference Intervals (CALIPER) has made significant strides towards improving pediatric healthcare in Canada and globally. The present report is a white paper summarizing CALIPER, and provides a comprehensive compendium of the data generated through this project over the past decade as a single resource for clinical laboratory specialists, clinicians, and other healthcare workers. CALIPER launched an outreach campaign in 2008 to recruit healthy community children and adolescents, and developed a robust statistical algorithm, in accordance with the Clinical and Laboratory Standards Institute (CLSI) guidelines, to develop accurate age- and sex-specific pediatric reference intervals. The first CALIPER direct reference interval study was published in 2012, with age- and sex-specific reference intervals reported for 40 common biochemical markers. To date, CALIPER has collected health information and blood samples from over 9700 community children and adolescents, and has established a comprehensive database of age- and sex-specific reference intervals for over 100 biomarkers of pediatric disease. CALIPER has also performed a series of transference and verification studies to expand the applicability of the CALIPER database to five major analytical platforms, including Abbott, Beckman, Ortho, Roche, and Siemens. Through novel knowledge translation initiatives, the CALIPER Reference Interval Database has been made freely available online ( www.caliperproject.ca ) as well as on a mobile application (CALIPER Reference App), and it is used by clinical laboratories across Canada, the United States, and globally. In addition to establishing this comprehensive pediatric reference interval database, CALIPER has also performed a series of sub-studies, including examining how reference intervals are affected by pre-analytical factors (i.e. sample stability at specific storage conditions, fasting status and time of sample collection), biological variation (i.e. intraindividual and interindividual biological variation, reference change values), and ethnicity and pubertal development stage. In this white paper, extensive tables of pediatric reference intervals are provided for easy reference for clinical laboratories worldwide. All data reported have been published in over 20 peer reviewed publications and are also available through the CALIPER Reference Interval Database as well as the CALIPER Reference App for mobile devices.

Entities:  

Keywords:  CALIPER; pediatric; reference intervals

Mesh:

Substances:

Year:  2017        PMID: 29017389     DOI: 10.1080/10408363.2017.1379945

Source DB:  PubMed          Journal:  Crit Rev Clin Lab Sci        ISSN: 1040-8363            Impact factor:   6.250


  32 in total

1.  Marked Influence of Adiposity on Laboratory Biomarkers in a Healthy Cohort of Children and Adolescents.

Authors:  Victoria Higgins; Arghavan Omidi; Houman Tahmasebi; Shervin Asgari; Kian Gordanifar; Michelle Nieuwesteeg; Khosrow Adeli
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

2.  CALIPER Hematology Reference Standards (I).

Authors:  Houman Tahmasebi; Victoria Higgins; Mary Kathryn Bohn; Alexandra Hall; Khosrow Adeli
Journal:  Am J Clin Pathol       Date:  2020-08-05       Impact factor: 2.493

3.  CALIPER Hematology Reference Standards (II).

Authors:  Victoria Higgins; Houman Tahmasebi; Mary Kathryn Bohn; Alexandra Hall; Khosrow Adeli
Journal:  Am J Clin Pathol       Date:  2020-08-05       Impact factor: 2.493

4.  The performance of glycated albumin as a biomarker of hyperglycemia and cardiometabolic risk in children and adolescents in the United States.

Authors:  Amelia S Wallace; Mary R Rooney; Tammy M Brady; Justin B Echouffo-Tcheugui; Robert Christenson; Morgan E Grams; Elizabeth Selvin
Journal:  Pediatr Diabetes       Date:  2021-12-26       Impact factor: 4.866

5.  An innovative approach based on real-world big data mining for calculating the sample size of the reference interval established using transformed parametric and non-parametric methods.

Authors:  Chaochao Ma; Li'an Hou; Yutong Zou; Xiaoli Ma; Danchen Wang; Yingying Hu; Ailing Song; Xinqi Cheng; Ling Qiu
Journal:  BMC Med Res Methodol       Date:  2022-10-20       Impact factor: 4.612

6.  The Beauty of Age-dependent Standardization in Pediatric Endocrine Research and Practice.

Authors:  Jaakko J Koskenniemi; Jorma Toppari
Journal:  J Clin Endocrinol Metab       Date:  2022-07-14       Impact factor: 6.134

7.  Complex biological patterns of soluble cytokines and CD163 in childhood necessitating age-specific reference intervals for evidence-based clinical interpretation.

Authors:  Lusia Sepiashvili; Zaman Alli; Mary Kathryn Bohn; Alexandra Hall; Amir Karin; Kazunori Murata; Khosrow Adeli
Journal:  Clin Biochem       Date:  2021-09-09       Impact factor: 3.625

8.  Reference Curves for Pediatric Endocrinology: Leveraging Biomarker Z-Scores for Clinical Classifications.

Authors:  Andre Madsen; Bjørg Almås; Ingvild S Bruserud; Ninnie Helen Bakken Oehme; Christopher Sivert Nielsen; Mathieu Roelants; Thomas Hundhausen; Marie Lindhardt Ljubicic; Robert Bjerknes; Gunnar Mellgren; Jørn V Sagen; Pétur B Juliusson; Kristin Viste
Journal:  J Clin Endocrinol Metab       Date:  2022-06-16       Impact factor: 6.134

9.  A prospective, cross-sectional study to establish age-specific reference intervals for neonates and children in the setting of clinical biochemistry, immunology and haematology: the HAPPI Kids study protocol.

Authors:  Monsurul Hoq; Vicky Karlaftis; Susan Mathews; Janet Burgess; Susan M Donath; John Carlin; Paul Monagle; Vera Ignjatovic
Journal:  BMJ Open       Date:  2019-04-03       Impact factor: 2.692

10.  Improving clinical paediatric research and learning from COVID-19: recommendations by the Conect4Children expert advice group.

Authors:  Athimalaipet V Ramanan; Neena Modi; Saskia N de Wildt
Journal:  Pediatr Res       Date:  2021-06-07       Impact factor: 3.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.